Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
21–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients do not have to be eligible for both modifications to be included in the study.
Lymphadenectomy vs no lymphadenectomy:
Patients 21 years or older scheduled for radical prostatectomy for treatment of prostate cancer with one of the consenting surgeons at MSKCC
Hemostatic agent vs. no hemostatic agent
Patients 21 years or older scheduled for minimally invasive radical prostatectomy for the treatment of prostate cancer with one of the consenting surgeons at MSKC
You may not be if
Lymphadenectomy vs no lymphadenectomy
Presence of positive/suspicious pelvic nodes on MRI, CT or PSMA scan (positive/suspicious defined as a pelvic node \>15mm in short axis on CT or MRI, a PSMA avid node, or a node with abnormal morphology such as roundness or irregularity or loss of fatty hilum)
Any prior pelvic radiation therapy used to treat prostate cancer
Hemostatic agent vs. no hemostatic agent
Clareo Health | Trial of Modifications to Radical Prostatectomy
